Epithelial-To-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fiction or Fact?
Journal Title: Pancreas – Open Journal - Year 2016, Vol 1, Issue 1
Abstract
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive and lethal tumors, representing the fourth most common cause of cancer death in the Western world, with an estimated incidence of more than 40,000 cases per year in the United States. Despite continuous progress in imaging, surgical techniques, intensive care, and chemotherapeutic approaches, the current overall 5-year survival is less than 6%.1,2
Authors and Affiliations
Nicoletta Gagliano
Genetic Therapy for Pancreatic Cancer: Is it the Future?
Although surgery is still the only curative therapy for pancreatic cancer, oncological therapies have started to be more and more promising. We firstly have to consider two important points. The first one is that surgery...
The Enigma of Type 3c Diabetes in Chronic Pancreatitis
Pancreatogenic or Type 3c diabetes (T3cDM) is relatively a new entry in the complex world of diabetes study. While the general population and physicians are well aware of type 1 and type 2 diabetes mellitus, as evidenced...
Recurrent Acute Pancreatitis: Dangerous Etiology?
Acute pancreatitis (AP) is a disorder clinically characterized by upper abdominal pain and elevated levels of pancreatic enzymes in the blood.1 After an initial evaluation, up to 10-30% of patients with AP are diagnosed...
Eus-Pancreaticogastrostomy in a Patient with Subtotal Gastrectomy and Roux-En-Y Reconstruction
Chronic Pancreatitis (CP) is often associated with pain due to pancreatic duct obstruction. In these patients, surgical drainage was more effective than endoscopic treatment, achieving a faster, effective, and sustained...
Nutritional Support of Patients With the Abdominal Compartment Syndrome During Severe Acute Pancreatitis
There is growing evidence in the literature that development of Abdominal Compartment Syndrome (ACS) in patients with Severe Acute Pancreatitis (SAP) has a strong impact on the course of disease. Incidence of ACS in pati...